MPM BioImpact’s BioCryst Pharmaceuticals BCRX Stock Holding History

MPM BioImpact’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$7.63M	Sell
2022 Q2	$6.76M	Hold
2022 Q1	$10.4M	Sell
2021 Q4	$9.17M	Sell
2021 Q3	$10.1M	Buy